These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33241466)

  • 1. Comparative study of topical regimen for adenoviral kearoconjunctivitis by 0.1% fluorometholone with and without polyvinyl alcohol iodine.
    Matsuura K; Terasaka Y; Miyazaki D; Shimizu Y; Inoue Y
    Jpn J Ophthalmol; 2021 Jan; 65(1):107-114. PubMed ID: 33241466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Investigation of Viral Load in Acute to Subacute Human Adenovirus Type 54 Conjunctivitis.
    Matsuura K; Terasaka Y; Miyazaki D; Shimizu Y; Inoue Y
    Jpn J Infect Dis; 2021 Nov; 74(6):567-569. PubMed ID: 33790064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human adenoviral type 54 keratoconjunctivitis accompanied by stellate keratitis and keratic precipitates: two cases.
    Matsuura K; Terasaka Y; Uchio E; Saeki Y; Fujimoto T; Hanaoka N; Miyazaki D; Inoue Y
    BMC Ophthalmol; 2019 Jan; 19(1):7. PubMed ID: 30616635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids Versus Cyclosporine for Subepithelial Infiltrates Secondary to Epidemic Keratoconjunctivitis: A Prospective Randomized Double-Blind Study.
    Gouider D; Khallouli A; Maalej A; Yousfi MA; Ksiaa I; Bouguerra C; Ajili F; Khairallah M
    Cornea; 2021 Jun; 40(6):726-732. PubMed ID: 33201059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis.
    Pelletier JS; Stewart K; Trattler W; Ritterband DC; Braverman S; Samson CM; Liang B; Capriotti JA
    Adv Ther; 2009 Aug; 26(8):776-83. PubMed ID: 19756415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A treatment protocol for minimizing duration and complications of adenoviral epidemic keratoconjunctivitis.
    Kulkarni C; Ballal K
    Taiwan J Ophthalmol; 2020; 10(4):269-277. PubMed ID: 33437600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of diluted povidone iodine in adenoviral keratoconjunctivitis on the rate of subepithelial corneal infiltrates.
    Altan-Yaycioglu R; Sahinoglu-Keskek N; Canan H; Coban-Karatas M; Ulas B
    Int J Ophthalmol; 2019; 12(9):1420-1425. PubMed ID: 31544037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
    Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
    Ophthalmology; 2002 May; 109(5):845-50. PubMed ID: 11986086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
    Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
    Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of adenoviral conjunctivitis at the early stage of infection.
    Aoki K; Kaneko H; Kitaichi N; Ohguchi T; Tagawa Y; Ohno S
    Jpn J Ophthalmol; 2011 Jan; 55(1):11-5. PubMed ID: 21331686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
    Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
    Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship between Clinical Findings and Viral Load in Adenoviral Keratoconjunctivitis.
    Isik P; Harbiyeli II; Ozturk G; Erdem E; Yagmur M; Yarkin F
    Jpn J Infect Dis; 2022 Nov; 75(6):592-596. PubMed ID: 35908877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of anti-adenoviral effects of the polyvinyl alcohol iodine ophthalmic solution.
    Tsukahara-Kawamura T; Hanaoka N; Uchio E
    Jpn J Ophthalmol; 2024 Jan; 68(1):64-69. PubMed ID: 37966563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Therapy of 0.1% Fluorometholone and 0.05% Azelastine in Eyes with Severe Allergic Conjunctival Diseases: A Randomized Controlled Trial.
    Chen M; Ke B; Zou J; Gong L; Wang Y; Zhang C; Xu J; Wei A; Hong J
    J Clin Med; 2022 Jul; 11(13):. PubMed ID: 35807160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial.
    Pinto-Fraga J; López-Miguel A; González-García MJ; Fernández I; López-de-la-Rosa A; Enríquez-de-Salamanca A; Stern ME; Calonge M
    Ophthalmology; 2016 Jan; 123(1):141-53. PubMed ID: 26520171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial.
    Cagini C; Mariniello M; Messina M; Muzi A; Balducci C; Moretti A; Levorato L; Mencacci A
    Int Ophthalmol; 2020 Dec; 40(12):3209-3215. PubMed ID: 32696102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of clinical signs, symptoms and point-of-care testing for early adenoviral conjunctivitis.
    Shorter ES; Whiteside MM; Harthan JS; Morettin CE; Perera CD; Johnson SD; Migneco MK; Huecker JB; Hartwick ATE; Than TP; Gordon MO
    Clin Exp Optom; 2022 Sep; 105(7):702-707. PubMed ID: 34751088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions.
    Labib BA; Minhas BK; Chigbu DI
    Clin Ophthalmol; 2020; 14():837-852. PubMed ID: 32256043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ganciclovir 0.15% ophthalmic gel in the treatment of adenovirus keratoconjunctivitis].
    Yabiku ST; Yabiku MM; Bottós KM; Araújo AL; Freitas Dd; Belfort R
    Arq Bras Oftalmol; 2011; 74(6):417-21. PubMed ID: 22331114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection and Molecular Characterization of Human Adenoviruses from Acute Conjunctivitis Cases].
    Tezcan Ülger S; Bekçi A; Yılmaz A; Aslan G
    Mikrobiyol Bul; 2019 Jul; 53(3):297-307. PubMed ID: 31414631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.